These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 33347820

  • 1. Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
    Luo P, Wang Y, Zhao C, Guo J, Shi W, Ma H, Liu T, Yan D, Huo S, Wang M, Li C, Lin J, Li S, Lv J, Zhang C, Lin L.
    Eur J Pharmacol; 2021 Feb 15; 893():173822. PubMed ID: 33347820
    [Abstract] [Full Text] [Related]

  • 2. Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE-/- mice.
    Luo P, Shi W, Wang Y, Ma H, Liu T, Yan D, Huo S, Guo J, Wang M, Li C, Lin J, Zhang C, Li S, Lv J, Lin L.
    Life Sci; 2020 Nov 15; 261():118304. PubMed ID: 32828944
    [Abstract] [Full Text] [Related]

  • 3. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar 15; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 4. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE-/- mice and inhibits monocyte/macrophage recruitment.
    Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R.
    Thromb Haemost; 2017 Jan 26; 117(2):401-414. PubMed ID: 27831589
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
    Wang J, Li P, Xu X, Zhang B, Zhang J.
    Front Immunol; 2020 Jan 26; 11():907. PubMed ID: 32655542
    [Abstract] [Full Text] [Related]

  • 6. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411243
    [Abstract] [Full Text] [Related]

  • 7. Quercetin Attenuates KLF4-Mediated Phenotypic Switch of VSMCs to Macrophage-like Cells in Atherosclerosis: A Critical Role for the JAK2/STAT3 Pathway.
    Xiang L, Wang Y, Liu S, Ying L, Zhang K, Liang N, Li H, Luo G, Xiao L.
    Int J Mol Sci; 2024 Jul 15; 25(14):. PubMed ID: 39062998
    [Abstract] [Full Text] [Related]

  • 8. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R, Sun Y, Liu R, Zhu B, Zhang H, Wu H.
    J Ethnopharmacol; 2024 Jun 12; 327():117969. PubMed ID: 38437888
    [Abstract] [Full Text] [Related]

  • 9. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
    Zhang L, Cheng H, Yue Y, Li S, Zhang D, He R.
    Cardiovasc Pathol; 2018 Jun 12; 33():6-15. PubMed ID: 29268138
    [Abstract] [Full Text] [Related]

  • 10. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W, Tang T, Nie D, Wen S, Jia C, Zhu Z, Xia N, Nie S, Zhou S, Jiao J, Dong W, Lv B, Xu T, Sun B, Lu Y, Li Y, Cheng L, Liao Y, Cheng X.
    Cardiovasc Res; 2015 Jun 01; 106(3):453-64. PubMed ID: 25784693
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S, Dong NG, Liu JP, Wang Y, Shi JW, Wei ZJ, Hu XJ, Gong L.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct 01; 33(5):615-622. PubMed ID: 24142708
    [Abstract] [Full Text] [Related]

  • 12. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL.
    Atherosclerosis; 2017 Jul 01; 262():39-50. PubMed ID: 28500865
    [Abstract] [Full Text] [Related]

  • 13. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 01; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

  • 14. IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway.
    Qian Z, Shaofang F, Chen C, Chunhua S, Nan W, Chao L.
    Cardiovasc Drugs Ther; 2024 Jun 01; 38(3):569-580. PubMed ID: 37957490
    [Abstract] [Full Text] [Related]

  • 15. The Inhibitory Effect of Ojeoksan on Early and Advanced Atherosclerosis.
    Han BH, Seo CS, Yoon JJ, Kim HY, Ahn YM, Eun SY, Hong MH, Lee JG, Shin HK, Lee HS, Lee YJ, Kang DG.
    Nutrients; 2018 Sep 06; 10(9):. PubMed ID: 30200674
    [Abstract] [Full Text] [Related]

  • 16. LOXL1-AS1/miR-515-5p/STAT3 Positive Feedback Loop Facilitates Cell Proliferation and Migration in Atherosclerosis.
    Xie Q, Li F, Shen K, Luo C, Song G.
    J Cardiovasc Pharmacol; 2020 Aug 06; 76(2):151-158. PubMed ID: 32453072
    [Abstract] [Full Text] [Related]

  • 17. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y.
    Atherosclerosis; 2017 Jun 06; 261():44-51. PubMed ID: 28445811
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit.
    Yang X, Jia J, Yu Z, Duanmu Z, He H, Chen S, Qu C.
    BMC Cardiovasc Disord; 2020 Mar 13; 20(1):133. PubMed ID: 32169038
    [Abstract] [Full Text] [Related]

  • 19. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
    He LH, Gao JH, Yu XH, Wen FJ, Luo JJ, Qin YS, Chen MX, Zhang DW, Wang ZB, Tang CK.
    Eur J Pharmacol; 2020 Oct 05; 884():173408. PubMed ID: 32739175
    [Abstract] [Full Text] [Related]

  • 20. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
    Chen J, Cao Z, Guan J.
    BMC Cardiovasc Disord; 2018 Apr 27; 18(1):72. PubMed ID: 29703160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.